ARYC Stock Overview

A life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. More details

ARYC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($1K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Arrayit Corporation Competitors

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

Lucy Scientific Discovery

OTCPK:LSDI.F

US$705.0

Hero Technologies

OTCPK:HENC

US$563.0

DermTech

OTCPK:DMTK.Q

US$3.5k

Price History & Performance

Summary of share price highs, lows and changes for Arrayit
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	n/a
3 Year Change	0%
5 Year Change	-99.99%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ARYC	US Life Sciences	US Market
7D	0%	0.9%	-2.1%
1Y	n/a	-0.7%	21.3%

Return vs Industry: Insufficient data to determine how ARYC performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how ARYC performed against the US Market.

Price Volatility

Is ARYC's price volatile compared to industry and market?
ARYC volatility
ARYC Average Weekly Movement	n/a
Life Sciences Industry Average Movement	9.3%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: ARYC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ARYC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Rene Schena	www.arrayit.com

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others.

Arrayit Corporation Fundamentals Summary

How do Arrayit's earnings and revenue compare to its market cap?
ARYC fundamental statistics
Market cap	US$1.13k
Earnings (TTM)	-US$6.53m
Revenue (TTM)	US$2.82m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is ARYC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ARYC income statement (TTM)
Revenue	US$2.82m
Cost of Revenue	US$1.43m
Gross Profit	US$1.39m
Other Expenses	US$7.92m
Earnings	-US$6.53m

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ARYC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/12 10:42
End of Day Share Price	2024/10/30 00:00
Earnings	2015/09/30
Annual Earnings	2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arrayit Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution